Drug discovery company Evotec upgrades IFS, setting the company up for the future & helping deliver on its ‘research never stops’ promise
Evotec is a fast-growing, global, high-quality provider in the drug discovery field and has a 20-year corporate history. Founded in 1993, the Company has built substantial drug discovery expertise and deep internal knowledge in the fields of metabolic diseases, neuroscience, pain, inflammation and oncology. By leveraging these skills and expertise, the company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Headquartered in Hamburg, Germany, the Evotec Group operates worldwide with subsidiaries in Germany, UK and USA.
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. Evotec operates worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic.
![](/-/media10/project/ifs/ifs/images/assets/customer/ifs_thumbnail_cs_evotec_01_2023_670x413px.png?h=413&iar=0&w=670&hash=0C9C787B0BABC82A4A45F5C37F8ED150)
"Having an out-of-thebox system made the upgrade easier and will be easier to support"
Senior Accountant, Evotec
About Evotec
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. Evotec operates worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic.
Benefits seen using IFS
- Enhanced reporting capabilities
- Seamless third party integrations
- 28% improvement in planned maintenance performance SLAs
- Upgrade completed ahead of schedule, bringing project in under budget